What AI says about SciGro

SciGro, Inc. accelerates the translation of research and preclinical technologies into commercial products for the pharmaceutical, biotechnology, medical diagnostics, and life sciences industries. The principals bring broad scientific expertise, notably in monoclonal antibodies and cytometric technologies, with senior-level clinical, research, and biomedical experience to support cost- and time-efficient development strategies. They offer services including SBIR/STTR grant proposal assistance, opportunity/technology assessments, design of clinical protocols and workflows, and management of small reagent product lines, helping clients speed research-to-development while conserving resources.